Abstract
Insulin is the cornerstone of therapy in patients with type 1 diabetes. Patients with type 2 diabetes who fail to achieve glycemic control with oral hypoglycemics are also treated with insulin. The clinical aim is to achieve glycemic control within, or close to, the normal physiological levels. Insulin is typically administered via intermittent subcutaneous injection or occasionally via subcutaneous infusion pump.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev. 2008;24:87–92.
Mégarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay JM, Baud FJ. Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care. 2007;11(5):R115.
Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med. 2012;366:1616–24.
Tofade TS, Liles EA. Intentional overdose with insulin glargine and insulin aspart. Pharmacotherapy. 2004;24(10):1412–8.
Yong AW, Morris Z, Shuler K, Smith C, Wardlaw J. Acute symptomatic hypoglycaemia mimicking ischaemic stroke on imaging: a systemic review. BMC Neurol. 2012;12:139.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Slater, LA., Stuckey, S.L., Chandra, R.V. (2015). Insulin. In: Ginat, D., Small, J., Schaefer, P. (eds) Neuroimaging Pharmacopoeia. Springer, Cham. https://doi.org/10.1007/978-3-319-12715-6_40
Download citation
DOI: https://doi.org/10.1007/978-3-319-12715-6_40
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12714-9
Online ISBN: 978-3-319-12715-6
eBook Packages: MedicineMedicine (R0)